Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbenicillin and ticarcillin

H C Neu

    The Medical Clinics of North America
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Carbenicillin and ticarcillin are crucial penicillins for treating severe Pseudomonas infections in hospitalized patients. Careful use ensures effectiveness and minimizes side effects like bleeding and hypokalemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postantibiotic effect of ceftibuten on respiratory pathogens.

    The Pediatric infectious disease journal·1995
    Same author

    Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.

    The Pediatric infectious disease journal·1995
    Same author

    In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.

    Antimicrobial agents and chemotherapy·1994
    Same author

    Emerging trends in antimicrobial resistance in surgical infections. A review.

    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·1994
    Same author

    Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

    Drugs·1993
    Same author

    Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

    The Journal of experimental medicine·1992
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Antimicrobial Therapy

    Background:

    • Carbenicillin and ticarcillin are penicillins developed for serious Pseudomonas infections.
    • These antibiotics have improved survival in neutropenic, burn, and cystic fibrosis patients.
    • Their applications have expanded to aspiration pneumonitis, sepsis, and Proteus/Enterobacter infections.

    Purpose of the Study:

    • To review the established and emerging uses of carbenicillin and ticarcillin.
    • To highlight the importance of understanding their pharmacology for effective treatment and safety.
    • To briefly introduce newer penicillins like azlocillin, mezlocillin, and piperacillin.

    Main Methods:

    • Literature review of penicillin use in serious infections.

    Related Experiment Videos

  • Analysis of clinical contributions and expanded therapeutic areas.
  • Discussion of pharmacological considerations and potential toxicities.

    • Main Results:

    • Carbenicillin and ticarcillin have demonstrated sustained efficacy when used judiciously.
    • These agents are vital for managing specific severe infections, including those caused by Pseudomonas.
    • Newer penicillins show promise but require further evaluation for definitive positioning.

    Conclusions:

    • Optimal use of carbenicillin and ticarcillin requires attention to their pharmacology to maximize efficacy and avoid adverse effects.
    • These penicillins remain valuable tools in treating serious bacterial infections.
    • Close correlation of in vitro data with clinical pharmacology is essential for newer agents like azlocillin, mezlocillin, and piperacillin.